Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A untrained probe marketed as an choice to a mammogram for knocker cancer detection is not an capable screening TOOL, US health officials say. With the nipple aspirate test, a heart of hearts cross-examine collects fluid from a woman's nipple. The protean is then examined for weird and potentially cancerous cells dailymotion. The examine is advertised as easier, more comfortable and less painful than mammograms.

However, there is no documentation to support claims that the test can feel breast cancer, said Dr David Lerner, a medical dignitary at the US Food and Drug Administration and a bosom imaging specialist. "FDA's worry is that the nipple aspirate assay is being touted as a standalone tool to screen for and determine breast cancer as an alternative to mammography," Lerner said in an force news release.

So "Our apprehension is that women will forgo a mammogram and have this check instead". Skipping a mammogram could put a woman's form and life at risk if breast cancer goes undetected, Lerner warned. He said there is no precise demonstration that the nipple aspirate test, when worn on its own, is an effective screening tool for heart cancer or any other medical condition.

The test is still being laboured to determine if it might be useful in combination with other methods to evaluate for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of teat cancer. Mammography is still the gold standard".

In October, 2013, Atossa Genetics pulled its nipple aspirate assess - called the ForeCYTE Breast Health Test - off the demand after being warned by the FDA that its claims about the trial were unsubstantiated. The cast claimed the proof was "literally a Pap cover for boob cancer". Pap smears are a guidon investigation for cervical cancer.

And Women who have had a nipple aspirate check-up as a form of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should verbiage to their poison about whether additional tests are needed, the FDA said. One in eight US women will expose soul cancer in her lifetime price. The plague is the second unrivalled cancer killer of women in the country.